Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or There's a common misconception about peptide injections that targeting them directly at pain sites is more effective than abdominal injection. However, when you inject peptides like BPC 157